Bell Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.2K Sell
420
-122
-23% -$7K ﹤0.01% 422
2026
Q1
$32.9K Buy
542
+80
+17% +$4.66K 0.01% 328
2025
Q4
$24.9K Buy
462
+97
+27% +$4.67K ﹤0.01% 387
2025
Q3
$16.5K Sell
365
-1,480
-80% -$69.1K ﹤0.01% 465
2025
Q2
$85.4K Buy
1,845
+1,321
+252% +$64.8K 0.01% 179
2025
Q1
$32K Buy
524
+12
+2% +$699 0.01% 285
2024
Q4
$29K Sell
512
-22
-4% -$1.23K 0.01% 304
2024
Q3
$27.6K Sell
534
-11
-2% -$516 0.01% 330
2024
Q2
$22.6K Sell
545
-992
-65% -$44.4K ﹤0.01% 371
2024
Q1
$83.4K Buy
1,537
+236
+18% +$12K 0.02% 152
2023
Q4
$66.8K Sell
1,301
-314
-19% -$16.5K 0.01% 169
2023
Q3
$93.7K Buy
1,615
+364
+29% +$22.3K 0.02% 126
2023
Q2
$80K Buy
1,251
+214
+21% +$14.3K 0.02% 128
2023
Q1
$71.9K Buy
1,037
+18
+2% +$1.27K 0.02% 130
2022
Q4
$73.3K Buy
1,019
+162
+19% +$12.2K 0.02% 127
2022
Q3
$61K Sell
857
-362
-30% -$26.3K 0.02% 115
2022
Q2
$94K Buy
+1,219
New +$92.8K 0.03% 91
2021
Q4
$49K Buy
789
+295
+60% +$17.3K 0.01% 159
2021
Q3
$29K Buy
+494
New +$32.5K 0.01% 216

Other funds holding BMY

Bell Investment Advisors's BMY Position: Q2 2026 in Review

Bell Investment Advisors reduced its Bristol-Myers Squibb (BMY) stake by 23% in Q2 2026, selling an estimated $7K and leaving 420 shares worth $24.2K. The position accounts for ﹤0.01% of the portfolio, ranked #422.

Bell Investment Advisors first reported a position in BMY in Q3 2021 and has held it in 19 quarters since. The position peaked at $94K in Q2 2022. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Bell Investment Advisors held 420 shares of Bristol-Myers Squibb worth $24.2K as of Q2 2026.
  • Bell Investment Advisors sold 122 Bristol-Myers Squibb shares in Q2 2026, an estimated $7K.
  • Bristol-Myers Squibb made up ﹤0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #422 holding.
  • Bell Investment Advisors first reported a position in Bristol-Myers Squibb in Q3 2021 and has held it in 19 quarters since.
  • Bell Investment Advisors's Bristol-Myers Squibb position peaked at $94K in Q2 2022.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.